Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Related Citations for PubMed (Select 24354242)

1.

[Increased expression of the c-Met receptor mRNA in gastric cancer].

Amemiya H, Peña A, Chiurillo M, Moscoso J, Useche A, Baffi R.

Invest Clin. 2013 Sep;54(3):284-98. Spanish.

PMID:
24354242
2.

Overexpression of the c-met protooncogene in human gastric carcinoma--correlation to clinical features.

Huang TJ, Wang JY, Lin SR, Lian ST, Hsieh JS.

Acta Oncol. 2001;40(5):638-43.

PMID:
11669338
3.

c-Met expression in gastric cancer with liver metastasis.

Amemiya H, Kono K, Itakura J, Tang RF, Takahashi A, An FQ, Kamei S, Iizuka H, Fujii H, Matsumoto Y.

Oncology. 2002;63(3):286-96.

PMID:
12381909
4.

Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.

Wang JY, Hsieh JS, Chen CC, Tzou WS, Cheng TL, Chen FM, Huang TJ, Huang YS, Huang SY, Yang T, Lin SR.

J Surg Res. 2004 Aug;120(2):242-8.

PMID:
15234219
5.

Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma.

Heideman DA, Snijders PJ, Bloemena E, Meijer CJ, Offerhaus GJ, Meuwissen SG, Gerritsen WR, Craanen ME.

J Pathol. 2001 Aug;194(4):428-35.

PMID:
11523050
6.

Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules.

Kim SY, Yoon J, Ko YS, Chang MS, Park JW, Lee HE, Kim MA, Kim JH, Kim WH, Lee BL.

BMC Cancer. 2011 Jun 22;11:264. doi: 10.1186/1471-2407-11-264.

7.

Functional expression of HGF and its receptor in human colorectal cancer.

Otte JM, Schmitz F, Kiehne K, Stechele HU, Banasiewicz T, Krokowicz P, Nakamura T, Fölsch UR, Herzig K.

Digestion. 2000;61(4):237-46.

PMID:
10878450
8.

[Role of the expression of c-Met receptor in the progression of gastric cancer].

Amemiya H, Menolascino F, Peña A.

Invest Clin. 2010 Sep;51(3):369-80. Spanish.

PMID:
21305773
9.

Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.

Lee J, Seo JW, Jun HJ, Ki CS, Park SH, Park YS, Lim HY, Choi MG, Bae JM, Sohn TS, Noh JH, Kim S, Jang HL, Kim JY, Kim KM, Kang WK, Park JO.

Oncol Rep. 2011 Jun;25(6):1517-24. doi: 10.3892/or.2011.1219. Epub 2011 Mar 18.

PMID:
21424128
10.

Expression of c-MET/HGF receptor mRNA and protein in human non-malignant and malignant prostate tissues.

Tsuka H, Mori H, Li B, Kanamaru H, Matsukawa S, Okada K.

Int J Oncol. 1998 Nov;13(5):927-34.

PMID:
9772281
12.

The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays.

Sotoudeh K, Hashemi F, Madjd Z, Sadeghipour A, Molanaei S, Kalantary E.

Diagn Pathol. 2012 May 28;7:57. doi: 10.1186/1746-1596-7-57.

13.

Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.

Uen YH, Lin SR, Wu CH, Hsieh JS, Lu CY, Yu FJ, Huang TJ, Wang JY.

Clin Chim Acta. 2006 May;367(1-2):55-61. Epub 2006 Jan 5.

PMID:
16403482
14.

Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.

Wu JG, Yu JW, Wu HB, Zheng LH, Ni XC, Li XQ, Du GY, Jiang BJ.

BMC Res Notes. 2014 Jan 6;7:6. doi: 10.1186/1756-0500-7-6.

15.

MET expression and amplification in patients with localized gastric cancer.

Janjigian YY, Tang LH, Coit DG, Kelsen DP, Francone TD, Weiser MR, Jhanwar SC, Shah MA.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1021-7. doi: 10.1158/1055-9965.EPI-10-1080. Epub 2011 Mar 10.

16.

High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.

Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, Peng JJ, Huang XH.

Ann Surg Oncol. 2009 Jan;16(1):208-19. doi: 10.1245/s10434-008-0214-6. Epub 2008 Nov 14.

PMID:
19009246
17.

c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.

Takeuchi H, Bilchik A, Saha S, Turner R, Wiese D, Tanaka M, Kuo C, Wang HJ, Hoon DS.

Clin Cancer Res. 2003 Apr;9(4):1480-8.

18.

Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.

Cheng TL, Chang MY, Huang SY, Sheu CC, Kao EL, Cheng YJ, Chong IW.

Chest. 2005 Sep;128(3):1453-60.

PMID:
16162743
19.

Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis.

Sun YL, Liu WD, Ma GY, Gao DW, Jiang YZ, Liu Q, Du JJ.

Int J Med Sci. 2013;10(5):548-59. doi: 10.7150/ijms.5191. Epub 2013 Mar 15.

20.

Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.

Kammula US, Kuntz EJ, Francone TD, Zeng Z, Shia J, Landmann RG, Paty PB, Weiser MR.

Cancer Lett. 2007 Apr 18;248(2):219-28. Epub 2006 Sep 1.

PMID:
16945480
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk